Case Background

On August 10, 2018, Aralez Pharmaceuticals US Inc., and 6 affiliated debtors (collectively, the "Debtors") each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York. The cases are pending before the Honorable Martin Glenn and are jointly administered under Case No. 18-12425.

Important Information & Dates

A hearing on the Debtors' First Day Motions was held on August 13, 2018 at 11:00 a.m. (ET) before the Honorable Martin Glenn, United Stats Bankruptcy Court for the Southern District of New York, One Bowling Green, Courtroom 523, New York, New York 10004.  A final hearing on certain of the First Day Motions will be held on September 13, 2018 at 10:00 a.m. 

Please click below to view and download the Debtors' First Day Motions and Orders:

First Day Motions

First Day Orders

Dates

August
10

Petition Date

 
September
13

Final Hearing on First D...

10:00 AM (ET)
August
10
 
August
13
10:00 AM (ET)
September
13
10:00 AM (ET)

Final Hearing on First Day Motions

Parties

Debtors' Counsel

Willkie Farr & Gallagher LLP

787 Seventh Avenue
New York, NY   10019
https://www.willkie.com
Phone: 212.728.8000
Fax: 212.728.8111
Paul V. Shalhoub
Robin Spigel
Debra C. McElligott

United States Trustee and Court Information

Office of the United States Trustee

U.S. Federal Office Building
201 Varick Street, Suite 1006
New York, NY   10014
http://www.usdoj.gov/ust/r02
Phone: 212.510.0500
Andrea B. Schwartz

United States Bankruptcy Court

Southern District of New York
One Bowling Green
New York, NY   10004-1408
http://www.nysb.uscourts.gov
Phone: 212.668.2870


Debtors

Case Number
Debtor Name
Petition Date
18-12425 Aralez Pharmaceuticals US Inc. August 10, 2018
18-12426 Aralez Pharmaceuticals Holdings Limited August 10, 2018
18-12427 Aralez Pharmaceuticals Management Inc. August 10, 2018
18-12431 POZEN Inc. August 10, 2018
18-12429 Aralez Pharmaceuticals Trading Designated Activity Company August 10, 2018
18-12430 Halton Laboratories LLC August 10, 2018
18-12428 Aralez Pharmaceuticals R&D Inc. August 10, 2018